With Donald Trump reaping his lowest approval rating of all-time, it’s only natural he’d scramble to throw voters a bone.

Apparently, that came in the form of a huge government-mediated discount on the blockbuster weight loss drugs known as GLP-1s, like Wegovy and Zepbound.

As reported by the Washington Post prior to the event, Trump announced the pharmaceutical giants Eli Lilly and Novo Nordisk will lower the price of their weight-loss drugs for some patients on Medicare and Medicaid.

In an Oval Office press conference, Trump called the deal a “triumph for American patients that will save lives and improve the health of millions and millions of Americans.” The companies have reportedly agreed to lower the price of their notoriously expensive suite of weight-loss GLP-1 drugs, likely as

See Full Page